1. Characteristics and clinical influence factors of arsenic species in plasma and their role of arsenic species as predictors for clinical efficacy in acute promyelocytic leukemia (APL) patients treated with arsenic trioxide. Issue 4 (3rd April 2021) Authors: Guo, Meihua; Zhou, Jin; Fan, Shengjin; Li, Limin; Chen, Hongzhu; Lin, Liwang; Zhao, Qilei; Wang, Xinyu; Liu, Wensheng; Wu, Zhiqiang; Hai, Xin Journal: Expert review of clinical pharmacology Issue: Volume 14:Issue 4(2021) Page Start: 503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol. Issue 10 (20th March 2021) Authors: Guo, Meihua; Zhao, Qilei; Fan, Shengjin; Wu, Zhiqiang; Lin, Liwang; Chen, Hongzhu; Gao, Yanhui; Hai, Xin Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 10(2021) Page Start: 4020 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical Characteristics and Outcome Analysis for HLA Loss Patients Following Partially Mismatched Related Donor Transplantation Using HLA Chimerism for Loss of Heterozygosity Analysis by Next-Generation Sequencing. (June 2022) Authors: Wang, Andi; Li, Wenjun; Zhao, Fei; Zheng, Zhongzheng; Yang, Ting; Wang, Sanbin; Yan, Jinsong; Lan, Jianpin; Fan, Shengjin; Zhao, Mingfeng; Shen, Jianpin; Li, Xin; Yang, Tonghua; Lu, Quanyi; Lu, Ying; Bai, Hai; Zhang, Haiyan; Cai, Dali; Wang, Ling; Yuan, Zhiyang Journal: Cell transplantation Issue: Volume 31(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Growth inhibition and suppression of the mTOR and Wnt/β‐catenin pathways in T‐acute lymphoblastic leukemia by rapamycin and MYCN depletion. Issue 2 (23rd December 2020) Authors: Kong, Desheng; Fan, Shengjin; Sun, Lili; Chen, Xi; Zhao, Yanqiu; Zhao, Linlin; Guo, Zhibo; Li, Yinghua Journal: Hematological oncology Issue: Volume 39:Issue 2(2021) Page Start: 222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia. Issue 2 (1st February 2022) Authors: Liu, Yabo; Li, Huibo; Zhao, Yanqiu; Li, Dandan; Zhang, Qian; Fu, Jinyue; Fan, Shengjin Journal: Bioengineered Issue: Volume 13:Issue 2(2022) Page Start: 2296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia. Issue 1 (28th August 2012) Authors: Zhang, Yingmei; Zhang, Zhuo; Li, Jinmei; Li, Limin; Han, Xueying; Han, Lina; Hu, Longhu; Wang, Shuye; Zhao, Yanhong; Li, Xiaoxia; Zhang, Ying; Fan, Shengjin; Lv, Chengfang; Li, Yinghua; Su, Yanhua; Zhao, Hui; Zhang, Xin; Zhou, Jin Journal: Cancer Issue: Volume 119:Issue 1(2013) Page Start: 115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. MYCN is a novel oncogenic target in adult B‐ALL that activates the Wnt/β‐catenin pathway by suppressing DKK3. Issue 7 (19th April 2018) Authors: Kong, Desheng; Zhao, Linlin; Sun, Lili; Fan, Shengjin; Li, Huibo; Zhao, Yanqiu; Guo, Zhibo; Lin, Leilei; Cui, Lin; Wang, Ke; Chen, Wenjia; Zhang, Yihui; Zhou, Jin; Li, Yinghua Journal: Journal of cellular and molecular medicine Issue: Volume 22:Issue 7(2018) Page Start: 3627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange. (28th March 2022) Authors: Li, Haitao; Gao, Chunlu; Lin, Liwang; Zhang, Gensheng; Fan, Shengjin; Hai, Xin Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 47:Number 8(2022) Page Start: 1232 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide. Issue 4 (3rd April 2019) Authors: Guo, Meihua; Wang, Bin; Liu, Shuchuan; Wang, Wenjing; Gao, Chunlu; Hu, Shuang; Fan, Shengjin; Hai, Xin; Zhou, Jin Journal: Expert review of clinical pharmacology Issue: Volume 12:Issue 4(2019) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗